RS17 is a synthetically designed antitumor peptide that specifically binds to the CD47 molecule, inhibiting the interaction between CD47 and its ligand SIRPalpha on the macrophage surface membrane. The primary regulatory mechanism of RS17 involves blocking the transmission of the selective phagocytosis signal from CD47 to SIRPalpha, preventing macrophages from identifying tumor cells as self, and instead treating them as foreign substances for phagocytosis, thereby inhibiting tumor cell immune evasion. RS17 is applicable in studies of antitumor responses and immune evasion mechanisms.
Molekulargewicht:
2120.24
CAS Nummer:
[2415545-08-1]
Formel:
C96H130N30O26
Target-Kategorie:
Interleukin
TP3575
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
